← Open Payments lookup

AHMED ABOUESH: Open Payments

NPI 1487661120 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$963 in 43 payments from 15 companies in 2025. Trend: 2023 $956 · 2024 $753 · 2025 $963

Food & beverage: $963
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$141
Teva Pharmaceuticals USA, Inc.7$139
Neurocrine BioSciences, Inc.4$113
ABBVIE INC.4$94
Axsome Therapeutics, Inc.4$91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$83
Vanda Pharmaceuticals Inc.3$63
E.R. Squibb & Sons, L.L.C.3$49
Janssen Pharmaceuticals, Inc1$39
Tris Pharma Inc2$34

Products named: INGREZZA, AUSTEDO XR, VRAYLAR, Auvelity, CAPLYTA, REXULTI, FANAPT, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.